Hypermarcas (OTCMKTS:HYPMY) Short Interest Up 183.8% in July

Hypermarcas (OTCMKTS:HYPMY) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 5,807 shares, a growth of 183.8% from the June 30th total of 2,046 shares. Based on an average trading volume of 27,320 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company’s stock are short sold.

Hypermarcas Price Performance

HYPMY stock opened at $4.15 on Wednesday. Hypermarcas has a 1-year low of $3.71 and a 1-year high of $5.50. The business has a fifty day moving average price of $4.13 and a 200-day moving average price of $4.38. The stock has a market capitalization of $2.92 billion, a P/E ratio of 8.65 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The company had revenue of $383.13 million for the quarter. As a group, analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on HYPMY. Zacks Research upgraded Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas presently has a consensus rating of “Buy”.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.